I finally burned through the leftover 50% allocation from October and topped up my Colgate-Palmolive position. Ten shares in total, average price $77.11, already sitting on a clean 4%+ profit. Nothing like making money off a company that’s been selling mint flavored foam since the Middle Ages.
My fresh November $1000 didn’t stay untouched for long. Texas Instruments got its share, because apparently even my portfolio wants to diversify into calculators from the 90s. But the real show was Novo Nordisk. The stock tanked on some genius headline about their Alzheimer’s adjacent miracle effect not being a miracle after all. I bought the drop. Two days later it was up 15%. Sometimes the market is cruel, chaotic, and borderline abusive but occasionally it hands you a win just to mess with your head.
Dividends? None. Zero. November was a cold, dry desert.
But December… December looks like the kind of month that makes dividend investors feel powerful, even if their payouts barely cover a coffee at Starbucks.